Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD).
Shulman M, Meyers-Ohki S, Novo P, Provost S, Ohrtman K, Van Veldhuisen P, Oden N, Otterstatter M, Bailey GL, Liu D, Rotrosen J, Weiss RD, Nunes EV.
Shulman M, et al. Among authors: bailey gl.
Contemp Clin Trials. 2025 Jan 20:107816. doi: 10.1016/j.cct.2025.107816. Online ahead of print.
Contemp Clin Trials. 2025.
PMID: 39842691